Clustering was based on n=244 GBM samples (238 patients, see Table 1) and n=40 phosphoproteins (including phosphorylated forms of ERK1/2, EGFR, and MET) (Figure 1A,B). This evidence concerns the gene MAPK3 and glioblastoma.